http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14020093

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 101
issn 1177-8881
pageRange 89-101
publicationName Drug Design, Development and Therapy
startingPage 89
bibliographicCitation Swords R, Mahalingam D, Padmanabhan S, Carew J, Giles F. Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. Drug Des Devel Ther. 2009 Sep 21;3():89–101. PMID: 19920925; PMCID: PMC2769239.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fe6dca519760d33d8076ed2e5f4d7e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de42f3ce31cf6da50179fcb307f24070
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef4d019496ddb8beadd1bfd38b964df3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea88c8ab488c524d2bae8bb0612b61e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_968e26e7c7303939337e837035febfde
date 2009-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19920925
https://pubmed.ncbi.nlm.nih.gov/PMC2769239
https://doi.org/10.2147/dddt.s3069
isPartOf https://portal.issn.org/resource/ISSN/1177-8881
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36020
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7978

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129367670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136071286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127474087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127902459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127476202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128499823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128974329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127403921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128966217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127656479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128299169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129708236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245381479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127692443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127718929

Total number of triples: 52.